The commission announced the investigations following concerns from advocacy groups, according to a Nov. 16 news release. The investigations will look to determine if the hospitals’ policies and practices regarding drug testing of pregnant people and newborns show discriminatory racial bias.
Although a positive toxicology test doesn’t merit a call to the State Central Register of Child Abuse and Maltreatment, some advocates say hospitals continue to use a single unconfirmed positive screen as a reason to report parents to the SCR. If the SCR accepts the report, the local child welfare agency is legally required to launch a child protection investigation.
At the time of publication, representatives from Montefiore Medical Center, Mount Sinai and NewYork-Presbyterian had not responded to Becker’s request for comment.
More articles on legal and regulatory issues:
Virginia physician convicted on 52 charges related to billing fraud scheme
Ohio hospital files antitrust suit against ProMedica
Kaiser pays $6.4M to settle false claims allegations
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
